Med. praxi. 2014;11(1):22-25
The effective management of chronic pain is fundamental goal for all clinicians, who treat the pain. Nociceptive and neuropathic pain
are two basic kinds of pain, which appears separetly or in combination. The three-step analgesic ladder developed by the World Health
Organisation (WHO) outlines these opioids in the management of cancer pain, and these widely accepted and extensively validated
guidelines have also been influential in the application of opioid therapy for treatment of chronic, non-malignant pain.
Potent opioids – such as morfin and the newer-generation agents (fentanyl, buprenorfin, oxycodon, hydromorfon and tapentadol) play
an important role in management of pain in patients with chronic pain. New opioid tapentadol is the first compound of the new pharmacological
class MOR-NRI, that combines μ-opioid-agonist and noradrenalin re-uptake inhibitor activities in one molecule.
Published: February 1, 2014 Show citation